Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia

International Journal of Cancer

Volumn 132, Issue 4, 2012, Pages 868-874

  Liu, Wei ^a   Wu, Lan ^a   Shen, Xue Min ^a   Shi, Lin Jun ^a   Zhang, Chen Ping ^a   Xu, Li Qun ^a   Zhou, Zeng Tong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

ALDH1; cancer stem cell marker; CD133; immunohistochemistry; leukoplakia; malignant transformation; oral cancer; oral dysplasia; outcome

Indexed keywords

CD133 ANTIGEN; PROTEIN ALDH1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER STEM CELL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; ANTIGENS, CD; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; ISOENZYMES; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; PEPTIDES; RETINAL DEHYDROGENASE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84871384381     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27720     Document Type: Article

References (30)

1. Ganly I, Patel S, Shah J,. Early stage squamous cell cancer of the oral tongue-clinicopathologic features affecting outcome. Cancer 2012; 118: 101-11.
2. Warnakulasuriya S,. Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 2010; 46: 407-10.
3. Zini A, Czerninski R, Sgan-Cohen HD,. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med 2010; 39: 299-305.
4. Zhang Z, Filho MS, Nör JE,. The biology of head and neck cancer stem cells. Oral Oncol 2012; 48: 1-9.
5. Sayed SI, Dwivedi RC, Katna R, et al. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol 2011; 47: 237-43.
6. Krishnamurthy S, Nör JE,. Head and neck cancer stem cells. J Dent Res 2012; 91: 334-40.
7. Gires O,. Lessons from common markers of tumor-initiating cells in solid cancers. Cell Mol Life Sci 2011; 68: 4009-22.
8. van der Waal I, Schepman KP, van der Meij EH, et al. Oral leukoplakia: a clinicopathological review. Oral Oncol 1997; 33: 291-301. (Pubitemid 28129229)
9. Liu W, Wang YF, Zhou HW, et al. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer 2010; 10: 685.
10. Tilakaratne WM, Sherriff M, Morgan PR, et al. Grading oral epithelial dysplasia: analysis of individual features. J Oral Pathol Med 2011; 40: 533-40.
11. Lodi G, Sardella A, Bez C, et al. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 2006; 4: CD001829.
12. Marcato P, Dean CA, Giacomantonio CA, et al. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 2011; 10: 1378-84.
13. Chen YC, Chen YW, Hsu HS, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009; 385: 307-13.
14. Clay MR, Tabor M, Owen JH, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 32: 1195-201.
15. Chen YC, Chang CJ, Hsu HS, et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol 2010; 46: 158-65.
16. Chen C, Wei Y, Hummel M, et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 2011; 6: e16466.
17. Sterz CM, Kulle C, Dakic B, et al. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncol 2010; 46: 116-22.
18. Chen YW, Chen KH, Huang PI, et al. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44(+)ALDH1(+) cells. Mol Cancer Ther 2010; 9: 2879-92.
19. Visus C, Ito D, Amoscato A, et al. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res 2007; 67: 10538-45. (Pubitemid 350070830)
20. Wu Y, Wu PY,. CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 2009; 18: 1127-34.
21. Hsu HS, Huang PI, Chang YL, et al. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. Cancer 2011; 117: 2970-85.
22. Zhang Q, Shi S, Yen Y, et al. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 2010; 289: 151-60.
23. Felthaus O, Ettl T, Gosau M, et al. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. Biochem Biophys Res Commun 2011; 407: 28-33.
24. Damek-Poprawa M, Volgina A, Korostoff J, et al. Targeted inhibition of CD133+ cells in oral cancer cell lines. J Dent Res 2011; 90: 638-45.
25. Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008; 14: 4085-95.
26. Ma S, Chan KW, Lee TK, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008; 6: 1146-53.
27. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-8.
28. Braakhuis BJ, Leemans CR, Brakenhoff RH,. A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 2004; 33: 317-22. (Pubitemid 38931752)
29. Sullivan JP, Spinola M, Dodge M, et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 2010; 70: 9937-48.
30. Nankivell P, Mehanna H,. Oral dysplasia: biomarkers, treatment, and follow-up. Curr Oncol Rep 2011; 13: 145-52.